Charles River Laboratorie...

NYSE: CRL · Real-Time Price · USD
157.44
1.64 (1.05%)
At close: Aug 15, 2025, 1:04 PM

Charles River Laboratories International Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 28, 2024 Dec 30, 2023 Dec 31, 2022 Dec 25, 2021
Net Income
25.29M 480.37M 492.61M 398.84M
Depreciation & Amortization
361.74M 314.12M 303.87M 265.54M
Stock-Based Compensation
69.89M 72.05M 73.62M 71.47M
Other Working Capital
-54.47M 13.78M 79.19M 49.83M
Other Non-Cash Items
375.41M -29.36M -62.02M 6.01M
Deferred Income Tax
-67.43M -50.9M -35.88M -24.01M
Change in Working Capital
-30.33M -102.38M -152.55M 42.94M
Operating Cash Flow
734.58M 683.9M 619.64M 760.8M
Capital Expenditures
-232.97M -318.53M -324.73M -228.77M
Cash Acquisitions
-5.48M -194.78M -120.12M -1.17B
Purchase of Investments
-52.88M -54.22M -158.27M -45.55M
Sales Maturities Of Investments
41.69M 6.67M 4.55M 6.53M
Other Investing Acitivies
4.55M -2.29M -9.35M 264K
Investing Cash Flow
-245.09M -563.15M -607.92M -1.44B
Debt Repayment
-412.19M -75.32M 19.79M 669.98M
Common Stock Repurchased
-119.17M -24.16M -38.65M -40.71M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-19.56M 13.96M -23.54M 43.32M
Financial Cash Flow
-550.93M -85.52M -42.4M 672.6M
Net Cash Flow
-78.91M 43.27M -5.1M 13.2M
Free Cash Flow
501.61M 365.37M 294.91M 532.03M